| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/13/1991 | EP0412508A1 Analogues of vasopressin, their preparation and pharmaceutical use |
| 02/12/1991 | US4992374 Mutant vaccinia virus and process for production thereof |
| 02/12/1991 | US4992273 Monoclonal antibodies secreted by hybridomas inhibits parasitic infections |
| 02/12/1991 | US4992272 Inactivated virus which retains immunogenicity |
| 02/12/1991 | US4992051 Containing deletion or insertion mutations; produce no antigen polypeptides |
| 02/12/1991 | CA1280072C Antigens related to the aids virus glycoprotein envelope, especially precursors of this glycoprotein, methods for obtaining theses antigens and measures applied in these methods, applications of these antigens to the preparation of immunogen compositions or for the diagnosis of aids or related conditions |
| 02/10/1991 | WO1991001996A1 Peptide fragments of hiv |
| 02/10/1991 | CA2064691A1 Peptide fragments of hiv |
| 02/07/1991 | WO1991001376A1 Antigenic protein specific for blood-propagated non-a non-b hepatitis, dna wich codes for said protein, and method of producing said protein |
| 02/07/1991 | WO1991001335A1 IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST |
| 02/07/1991 | WO1991001143A1 Stable vaccine compositions containing interleukins |
| 02/07/1991 | WO1991001138A1 Sequential heat treatment of blood-clotting factor products |
| 02/07/1991 | WO1991001134A1 Novel lipid a derivatives and uses therefor |
| 02/07/1991 | WO1991001133A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 02/07/1991 | WO1990015141A3 Self-assembled, defective, non-self-propagating viral particles |
| 02/07/1991 | WO1990014068A3 Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof |
| 02/06/1991 | EP0412050A1 Novel cytokines |
| 02/06/1991 | EP0411896A2 Growth medium and fermentation process |
| 02/06/1991 | EP0411893A2 Chimeric antibodies directed against a human glycoprotein antigen |
| 02/06/1991 | EP0411684A2 New antigenically active proteins/peptides, and feline infectious virus (FIPV)-vaccines |
| 02/06/1991 | EP0231209B1 Virus vaccine |
| 02/05/1991 | WO1991001753A1 Inhibition of tumor growth by blockade of the protein c system |
| 02/05/1991 | US4990596 Synthetic peptide producing antibodies of enhanced binding to human LDH-C4 |
| 02/05/1991 | US4990443 Testosterone-3-dimethyl-carboxymethoxime-peroxidase or estradiol-6-dimethyl-carboxymethoxime peroxidase |
| 02/05/1991 | US4990367 Canine distemper virus vaccine |
| 02/03/1991 | WO1991001749A1 Method of treatment with medical agents |
| 02/01/1991 | CA2022273A1 Chimeric antibodies directed against a human glycoprotein antigen |
| 02/01/1991 | CA2022108A1 Enhanced growth and expression of heterologous proteins in recombinant hosts containing mutations in cell wall and/or plasma membrane biosynthesis |
| 01/30/1991 | EP0410848A1 Process for combining a mixture of heterogeneous substances with liposomes |
| 01/30/1991 | EP0410813A1 Anti-human BCDF monoclonal antibody and immunoassay using the same |
| 01/30/1991 | EP0410748A1 Avipox virus promoters |
| 01/30/1991 | EP0410713A1 Polypeptide inhibitor of viral replication |
| 01/30/1991 | EP0410246A1 Erythropoietin(EPO)-peptides and antibodies against them |
| 01/30/1991 | EP0410178A1 CD4-fragment having anti-HIV activity |
| 01/30/1991 | EP0410147A1 Modified VP1/P2A regions of rhinovirus systems |
| 01/30/1991 | EP0409963A1 Immunoassay for fast homoarginine-sensitive alkaline phosphatase (fhap) and antibody useful therewith |
| 01/30/1991 | EP0409923A1 EXPRESSION OF THE i(PLASMODIUM) CIRCUMSPOROZOITE PROTEIN IN INSECT CELLS |
| 01/30/1991 | EP0177531B1 Antibodies, manufacture and use |
| 01/29/1991 | WO1991001751A1 Biological preparation and its use |
| 01/29/1991 | CA2022185A1 Separation of anti-metal chelate antibodies |
| 01/28/1991 | WO1991001750A1 Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines |
| 01/28/1991 | CA2064194A1 Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines |
| 01/28/1991 | CA2022033A1 Method for combining a mixture of heterogeneous substances with liposomes |
| 01/27/1991 | WO1991002072A1 Avipox virus promoters |
| 01/27/1991 | CA2063725A1 Avipox virus promoters |
| 01/26/1991 | WO1991001329A1 Polypeptide inhibitor of viral replication |
| 01/26/1991 | WO1991001145A1 Pokeweed antiviral protein - monoclonal antibody conjugates |
| 01/26/1991 | CA2063801A1 Polypeptide inhibitor of viral replication |
| 01/24/1991 | WO1991000919A1 Promoters of colony stimulating factor activity |
| 01/24/1991 | WO1991000914A1 Production of antigens by self-assembly of polypeptide components |
| 01/24/1991 | WO1991000741A1 Use of bluetongue virus proteins as vaccine components |
| 01/24/1991 | WO1991000737A1 Treatment of obesity and essential hypertension and related disorders |
| 01/24/1991 | WO1990015132A3 Cloned treponema hyodysenteriae endoflagellar antigen |
| 01/24/1991 | WO1990014881A3 Chelating agents for attaching metal ions to proteins |
| 01/24/1991 | CA2075945A1 Use of bluetongue virus proteins as vaccine components |
| 01/24/1991 | CA2075896A1 Production of antigens by self-assembly of polypeptide components |
| 01/24/1991 | CA2035861A1 Promoters of colony stimulating factor activity |
| 01/23/1991 | EP0409607A2 Antibody to human interleukin-6 receptor |
| 01/23/1991 | EP0409242A1 Monoclonal antibody against human CD4 peptide |
| 01/23/1991 | EP0409212A2 Stabilization of analytes |
| 01/23/1991 | EP0409091A1 Antagonists of GM-CSF derived from the carboxyl terminus |
| 01/23/1991 | EP0409040A1 Antibodies to Promoters of colony stimulating factor activity |
| 01/23/1991 | EP0408859A2 Monoclonal antibodies to activated endothelial cells |
| 01/23/1991 | EP0408663A1 Peptides inhibitors of hiv induced cell fusions and syncytia formation |
| 01/23/1991 | EP0408651A1 Isoferritin as a marker for pathological pregnancy |
| 01/23/1991 | EP0408585A1 Immobilized artificial membranes |
| 01/23/1991 | EP0183780B1 Distinguishing subsets of human cells |
| 01/22/1991 | WO1991001332A1 Feline calicivirus capsid protein and nucleotide sequence |
| 01/22/1991 | WO1991001150A1 Anthelmintic non-living vaccine |
| 01/22/1991 | US4987237 Immunostimulant suitable for coupling to other materials |
| 01/22/1991 | CA2060651A1 Anthelmintic non-living vaccine |
| 01/22/1991 | CA1279277C Treponema hyodysenteriae bacterin and process therefor |
| 01/22/1991 | CA1279276C Polypeptides and antibiotics characteristic of papillomavirus and use for the in vitro diagnostic, the prevention and/or the control of papillomavirus infections |
| 01/20/1991 | CA2021430A1 Stabilization of analytes |
| 01/17/1991 | DE4020211A1 New rhinoviral DNA with mutation(s) in protease 2A region - and corresponding oligo:nucleotide(s) and oligopeptide(s), useful in test systems and as therapeutic competitive inhibitors |
| 01/16/1991 | EP0408444A2 Galactan extracted Klebsiella, process for its preparation and its use as a medicament |
| 01/16/1991 | EP0408301A1 DNA coding for a polypeptide signal sequence in vaccinia virus |
| 01/16/1991 | EP0408294A2 Use of an amylin antagonist for the manufacture of amedicament for the treatment of obesity and essential hypertension and related disorders |
| 01/16/1991 | EP0408157A1 Acid-cleavable compound |
| 01/16/1991 | EP0407813A2 Oxidative denaturation of protein analytes |
| 01/16/1991 | EP0407543A1 Mammalian gap-43 compositions and methods of use |
| 01/16/1991 | EP0407515A1 A live vaccine against newcastle disease |
| 01/16/1991 | EP0407462A1 Dna binding proteins including androgen receptor |
| 01/16/1991 | EP0407451A1 General cancer-associated scm-recognition factor, preparation and method of use |
| 01/16/1991 | EP0407430A1 Therapeutic murine monoclonal antibody |
| 01/16/1991 | EP0407399A1 Immunosupression with anti-pan t-cell immunotoxin compositions |
| 01/16/1991 | EP0118547B1 Method for the preparation of glucosyltransferase |
| 01/15/1991 | WO1991001333A1 Methods of treating or preventing autoimmune uveoretinitis in mammals |
| 01/15/1991 | WO1991001330A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/15/1991 | WO1991001146A1 Cytokine and hormone carriers for conjugate vaccines |
| 01/15/1991 | US4985244 Stabilized live attenuated vaccine and its production |
| 01/15/1991 | US4985243 Endonuclease |
| 01/15/1991 | US4985144 Purification of protein antigens |
| 01/15/1991 | CA2063271A1 Cytokine and hormone carriers for conjugate vaccines |
| 01/15/1991 | CA2062975A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/15/1991 | CA1279012C Process for preparing immunogenic complexes and pharmaceutical composition containing these complexes |
| 01/13/1991 | CA2020740A1 Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines |
| 01/12/1991 | WO1991000911A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 01/12/1991 | CA2063389A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 01/12/1991 | CA2020794A1 Galactanne extracted from klebsiella, process for its obtention and use as medicament |